Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis
Condition: Recurrent Respiratory PapillomatosisIntervention: Biological: Human Papillomavirus Quadrivalent VaccineSponsors: University of Missouri-Columbia; University of Missouri-ColumbiaWithdrawn - verified January 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cervical Cancer Vaccine | Genital Warts | Human Papillomavirus (HPV) | Papillomatosis | Research | Respiratory Medicine | Vaccines